Skip to main content
HQY logo

HealthEquity, Inc. (HQY) Stock: Price, Forecast & Analyst Target

HealthEquity, Inc. (HQY) — MoonshotScore 90/100 (Exceptional band), calculated Nov 18, 2026. Price $97.31 (-4.45%), as of the Nov 18, 2026 trading session; market cap $8.05B. Expected results Dec 1, 2026.

Educational signal · not a buy or sell recommendation · How to read this

Market value / cash and short-term investments: 31.45× (cash as of Jul 31, 2026) · expected results Dec 1, 2026

$97.31 −$4.53 (-4.45%) Market Cap $8.05B

HealthEquity, Inc. · HQY · NASDAQ · Healthcare · Health Information Services

Research dated 2026-09-13: HealthEquity administers tax-advantaged health accounts and related benefits through a cloud platform, while also earning from payment activity and the economics of HSA cash. Its case depends on whether expanding account economics and operating leverage can keep lifting profit and cash generation while debt remains well above cash.

Price as of Nov 18, 2026

Key Statistics

90 of 100

MoonshotScore v2 · HealthEquity (HQY)

Exceptional
Business Quality Elite (89)
Financial Safety Sound (72)
Valuation Full (51)
Growth Durability Compounding (94)
Momentum Surging (81)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality, a strong balance sheet and elite growth, but a full valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Full; Growth Durability: Compounding; Momentum: Surging.

  • EPS beat 7 of the last 8 reports
  • Altman Z 4.88 · Piotroski F 8
  • ROE 11.4% · ROA 7.2% · current ratio 2.99 · earnings yield 2.8% · free-cash-flow yield 5.6%

Helping: business quality, balance-sheet strength, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for HQY (57 recorded, newest six shown)
RecordedScoreBand
91Exceptional
91Exceptional
91Exceptional
91Exceptional
90Exceptional
90Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$97.31
Change on the day-4.45%
52-week range$72.76–$110.26
Market capitalisation$8.05B—
Price / earnings (trailing)36.37
Shares traded on the day1.29M
Beta (volatility vs the S&P 500)0.19

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $74, high $105, latest $97. 4 reported quarters marked, 4 above and 0 below the recorded estimate. 1 other dated event marked. $105 $74 high $105 Dec 3, 2025 · Earnings results · reported above the recorded estimate · close $951Mar 17, 2026 · Earnings results · reported above the recorded estimate · close $812May 28, 2026 · Earnings results · reported above the recorded estimate · close $883Aug 27, 2026 · Earnings call · management outlook · no recorded estimate to compare · close $964Aug 27, 2026 · Earnings results · reported above the recorded estimate · close $965 Oct 17, 2025 Nov 18, 2026 · $97 $91Oct 17, 2025$95Oct 31, 2025$102Nov 14, 2025$105Nov 28, 2025$97Dec 12, 2025$93Dec 26, 2025$94Jan 9, 2026$84Jan 23, 2026$79Feb 6, 2026$79Feb 20, 2026$78Mar 6, 2026$81Mar 20, 2026$85Apr 2, 2026$86Apr 17, 2026$82May 1, 2026$82May 15, 2026$88May 29, 2026$88Jun 12, 2026$88Jun 26, 2026$94Jul 10, 2026$95Jul 24, 2026$105Aug 7, 2026$105Aug 21, 2026$96Sep 4, 2026$95Sep 18, 2026$90Oct 2, 2026$92Oct 16, 2026$102Oct 30, 2026$103Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings call · management outlook
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate

Management outlook

  • For fiscal 2027, we now expect revenue between $1.411 billion and $1.421 billion.

    James Lucania · Statement from

  • Second, as a reminder of the cadence we set last year, we expect to publish year-end sales metrics after the conclusion of our January 31st fiscal year, and we will provide fiscal 2028 guidance when we report our fiscal 2027 year-end financial results.

    Richard Putnam · Statement from

How to read these dates

A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.

Read management statements

Other perspectives

Council score for HealthEquity (HQY): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Strong
Financial Safety Moderate
Valuation Neutral
Growth Durability Strong
Momentum Strong

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Favorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Fairly Valued
Profit Margin Moderate
Revenue Growth Neutral
Debt/Equity Neutral
ROE Neutral
Gross Margin Strong

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

One of these lenses reads this company less favourably than the MoonshotScore does: Klarman-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is HealthEquity (HQY), and what does it report?

Short answer · as of

HealthEquity is not a healthcare provider. It supplies the account infrastructure through which consumers and employers manage health savings, flexible spending, reimbursement arrangements, continuation coverage and commuter benefits, with tools for bill payment, cost comparison and investing.

Reported revenue blends service fees, credit and debit card activity, and other financial services. Those lines measure administration, platform usage, payment activity and financial economics rather than the volume of medical care delivered.

2 · Latest results

What do the latest results show for HealthEquity (HQY)?

Revenue eased from the preceding quarter but remained above the comparable prior period. Operating profit, net income and diluted earnings also stepped down sequentially while staying ahead of their prior-period counterparts.

Across the annual series, revenue advanced throughout the reported span as losses gave way to rising profits, even while research and development spending increased. The recent earnings record also shows repeated revenue and earnings beats against estimates.

Management currently expects further annual revenue expansion and explicitly includes the average yield on HSA cash among its outlook assumptions. That yield is a stated business sensitivity, not a demonstrated explanation for every quarterly movement.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Latest quarter · revenue
$350.73M Jul 31, 2026
Latest quarter · R&D
$73.92M Jul 31, 2026
Latest quarter · SG&A
$58.08M Jul 31, 2026
Latest quarter · FMP standardized operating result
$98.69M Jul 31, 2026
Period endRevenueR&DSG&AFMP standardized operating result
Jul 31, 2026$350.73M$73.92M$58.08M$98.69M
Apr 30, 2026$354.64M$67.77M$57.96M$102.95M
Jan 31, 2026$334.59M$70.35M$171.43M$67.37M
Oct 31, 2025$322.16M$65.92M$55.29M$79.85M
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$350.70M Aug 27, 2026
Latest report · revenue estimate
$349.22M Aug 27, 2026
Latest report · revenue vs estimate
Above estimate Aug 27, 2026
Latest report · EPS vs estimate
Above estimate Aug 27, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Aug 27, 2026$350.70M$349.22M$1.2400$1.1900
May 28, 2026$354.64M$352.02M$1.2400$1.1100
Mar 17, 2026$334.60M$332.32M$0.9500$0.8900
Dec 3, 2025$322.20M$320.63M$1.0100$0.9120
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Jul 2025$326M$60M$0.68 (diluted)
Q3 FY2026$322M$52M$0.59 (diluted)
Q4 FY2026$335M$50M$0.58 (diluted)
Q1 FY2027$355M$69M$0.82 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for HealthEquity (HQY)?

Short answer

Cash and short-term investments were $256.00M at the Jul 31, 2026 balance-sheet date. Operating cash flow was $136.16M for the quarter ended Jul 31, 2026, meaning operations generated cash. These figures do not establish a cash runway.

Operating cash flow was positive in every reported quarter and strengthened in the latest period, while recent capital expenditure was modest. That cash generation supplies internal capacity for growth initiatives and capital allocation.

Debt substantially exceeds cash and short-term investments, and the cash balance has declined across the reported window despite positive operating cash flow. Supportive liquidity ratios and financial-quality screens reduce immediate strain but do not remove the balance-sheet tradeoffs.

A weaker yield on HSA cash could pressure an earnings mechanism that management explicitly incorporates into its outlook. Growth spending, repurchases, revolver reduction and portfolio acquisitions must also compete for the same financial capacity.

How much cash does the business generate or use?

Quarterly operating cash flow shows cash generated or used by operations.

Latest quarter · operating cash flow
$136.16M Jul 31, 2026
Previous quarter · operating cash flow
$97.53M Apr 30, 2026
Period endOperating cash flowCapital expenditure (reported)
Jul 31, 2026$136.16M−$980,000
Apr 30, 2026$97.53M−$360,000
Jan 31, 2026$117.92M−$16.38M
Oct 31, 2025$138.57M−$780,000
How to read these figures

Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.

4 · What to check next?

What should you watch next at HealthEquity (HQY)?

Short answer · as of

The next earnings report is expected on Dec 1, 2026.

The scheduled earnings report carries a revenue expectation slightly below the latest result. Watch whether revenue stabilizes, operating profit resumes its advance and operating cash flow remains firm; recent estimate beats make the comparison with expectations relevant, but the underlying direction matters more than another beat.

Beyond the headline result, watch the realized yield on HSA cash, the year-end sales metrics when published, and the allocation of cash among repurchases, revolver reduction and portfolio acquisitions. Management has identified each of these as an upcoming operating or capital-allocation consideration.

What management is planning

Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.

  1. We now expect average yield on HSA cash to be between 3.85% and 3.9% during fiscal 2027.

    James Lucania ·

  2. Our guidance also reflects funding growth initiatives in the second half of the year, expected capital allocation activity, including additional share repurchase under the expanded authorization, and potential reductions in revolver borrowings during the year. With continued strong cash flow and revolver availability, we expect to maintain ample capacity for portfolio acquisitions should attractive opportunities become available.

    James Lucania ·

2 more statements are quoted under Upcoming events

5 · Peer comparison

How does HealthEquity compare with its peers?

Short answer

HealthEquity's score ranks 3rd of 6 in the bounded comparison shown, against 5 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

HealthEquity combines benefits administration with payment and custodial-financial economics. Service revenue sits beside card revenue and other financial services, while the platform spans health savings, flexible spending, reimbursement arrangements, continuation coverage and commuter benefits.

That mix makes account balances, HSA cash yield, member payment activity and administration demand relevant at the same time. A comparison based only on benefits-software fees would therefore miss material parts of how HealthEquity earns revenue.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Globus Medical, Inc. (GMED) Named competitor$70.53 Nov 18, 2026$9.34B94 5-pillar Nov 18, 2026
Penumbra, Inc. (PEN) Named competitor$320.00 Nov 19, 2026$12.6B92 5-pillar Nov 18, 2026
HealthEquity (HQY) — this page$97.31$8.05B90
BrightSpring Health Services, Inc. (BTSG) Named competitor$68.34 Nov 18, 2026$13.6B87 5-pillar Nov 18, 2026
DaVita Inc. (DVA) Named competitor$156.24 Nov 19, 2026$9.83B76 5-pillar Nov 18, 2026
Molina Healthcare, Inc. (MOH) Named competitor$206.56 Nov 18, 2026$10.8B68 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$108.00 – $142.00
Consensus target
$118.14
Median target
$115.00

Consensus record · Captured .

Measured against a quoted price of $97.31 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 15, 2026

Transactions
35
Identified insiders
15
Purchases
2
Sales
8
Other transactions
25

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Reporting holders
533 Period end Sep 30, 2026
Previous quarter · holders
512 Prior to period end Sep 30, 2026
Holders in provider snapshotShares
Blackrock, INC.11,301,328
Wasatch Advisors LP7,011,469
Vanguard Portfolio Management LLC3,951,899
Morgan Stanley3,806,596
Vanguard Capital Management LLC3,575,041

Tracked investors

Which of the 16 named investors we follow held HQY in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported HQY in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about HealthEquity (HQY)?

Read these with our analysis →

HQY Healthcare Stock FAQ

The last 2 questions are answered from this page's own dated data, not from the research.

How does Advisor extend HealthEquity’s HSA platform?

Advisor adds automated online guidance and investment choices to account administration, allowing members to manage and grow health savings within the broader platform.

Why does HealthEquity disclose the yield on HSA cash?

Management treats the yield earned on HSA cash as an outlook assumption, showing that account balances contribute financial economics alongside service and card revenue. A lower realized yield would weaken that contribution unless offset elsewhere.

How do COBRA and commuter benefits fit into HealthEquity?

COBRA continuation services and pretax commuter programs broaden HealthEquity beyond health savings accounts. They place additional employer-benefit administration on the same general platform and distribution network.

Can HealthEquity fund buybacks while reducing its revolver?

Positive operating cash flow provides capacity for capital allocation, and management expects repurchases and possible revolver reductions. Debt remains well above cash, however, so buybacks, repayment, growth spending and acquisitions remain competing uses of funds.

What is the HQY stock price today?

The last price recorded for HealthEquity, Inc. (HQY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the HQY price target?

The analyst consensus price target for HealthEquity, Inc. (HQY), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 78 figures on this page — 1 from SEC filings and earnings calls, 69 from Financial Modeling Prep (FMP), 4 with no recorded source, 3 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Annual revenue and net result (USD millions); Operating cash flow by quarter (USD millions); Cash, investments and debt; Management outlook — dated call excerpts
  • 1. What is HealthEquity (HQY), and what does it report?: Business description; Sector / industry (provider taxonomy); Revenue by segment
  • 2. What do the latest results show for HealthEquity (HQY)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Reported versus estimated, last 8 quarters; Analyst revenue and earnings estimates (average); Management outlook — dated call excerpts
  • 3. What are the financial strengths and risks for HealthEquity (HQY)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash against market value; Trailing twelve-month ratio set; Distress and quality screens; Management outlook — dated call excerpts
  • 4. What should you watch next at HealthEquity (HQY)?: Next earnings report; Reported versus estimated, last 8 quarters; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Management outlook — dated call excerpts
  • 5. How does HealthEquity compare with its peers?: Business description; Revenue by segment; Management outlook — dated call excerpts
  • FAQ: How does Advisor extend HealthEquity’s HSA platform?: Business description
  • FAQ: Why does HealthEquity disclose the yield on HSA cash?: Management outlook — dated call excerpts; Revenue by segment
  • FAQ: How do COBRA and commuter benefits fit into HealthEquity?: Business description
  • FAQ: Can HealthEquity fund buybacks while reducing its revolver?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash against market value; Management outlook — dated call excerpts
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.